IAEA Atlas of Cardiac PET/CT
A Case-Study Approach
Buch in deiner Nähe kaufen
Beschreibung
The second edition of this Open Access book presents an expanded portfolio of examples of positron emission tomography coupled with computed tomography (PET/CT) studies in various cardiac conditions, providing a rationale for the implementation of this technology in an array of clinical conditions.
Cardiovascular diseases (CVDs) are a major contributor to premature morbidity and mortality worldwide. Low- and middle-income countries (LMICs) are particularly affected by CVDs, with more than 75% of all CVD deaths occurring in these regions. Consequently, target 3.4 of the United Nations (UN) Sustainable Development Goals (SDGs) agenda aims for a 30% reduction in premature mortality due to non-communicable diseases (NCDs), including CVDs, by 2030.
Among CVDs, ischaemic heart disease (IHD) plays a significant role. According to the Institute for Health Metrics and Evaluation (IHME), IHD was responsible for 15.96% of global deaths in 2017. Between 2000 and 2017, the number of IHD deaths worldwide increased by 0.26% per year.
Several imaging tools help to non-invasively diagnose, stratify risk and guide management in cardiac disease. These include nuclear cardiology techniques, using either SPECT (single photon emission computed tomography) or PET/CT. While myocardial imaging with SPECT has been fully embraced by the cardiology community and is widely available worldwide, the introduction of PET/CT has been slower due not only to its higher costs but also to the limited availability of PET/VCT scanners, mostly utilized for oncological applications.
This book is an invaluable tool for nuclear medicine physicians, cardiologists and radiologists.
The second edition of this Open Access book presents an expanded portfolio of examples of positron emission tomography coupled with computed tomography (PET/CT) studies in various cardiac conditions, providing a rationale for the implementation of this technology in an array of clinical conditions.
Cardiovascular diseases (CVDs) are a major contributor to premature morbidity and mortality worldwide. Low- and middle-income countries (LMICs) are particularly affected by CVDs, with more than 75% of all CVD deaths occurring in these regions. Consequently, target 3.4 of the United Nations (UN) Sustainable Development Goals (SDGs) agenda aims for a 30% reduction in premature mortality due to non-communicable diseases (NCDs), including CVDs, by 2030.
Among CVDs, ischaemic heart disease (IHD) plays a significant role. According to the Institute for Health Metrics and Evaluation (IHME), IHD was responsible for 15.96% of global deaths in 2017. Between 2000 and 2017, the number of IHD deaths worldwide increased by 0.26% per year.
Several imaging tools help to non-invasively diagnose, stratify risk and guide management in cardiac disease. These include nuclear cardiology techniques, using either SPECT (single photon emission computed tomography) or PET/CT. While myocardial imaging with SPECT has been fully embraced by the cardiology community and is widely available worldwide, the introduction of PET/CT has been slower due not only to its higher costs but also to the limited availability of PET/VCT scanners, mostly utilized for oncological applications.
This book is an invaluable tool for nuclear medicine physicians, cardiologists and radiologists.
This book is open access, which means that you have free and unlimited access The objective of this publication is to present a case-based analysis of the main indications for PET/CT in cardiology Provides nuclear cardiology practitioners to understand the value of PET/CT in appropriate clinical conditions This book is an invaluable tool for nuclear medicine physicians, cardiologists and radiologists
Autor*in
Marcelo Di Carli
Themen in »IAEA Atlas of Cardiac PET/CT«
Open Access Nuclear cardiology Quantitative PET in cardiology Ischemic heart disease Infiltrative cardiomyopathies PET in vasculatides Myocardial blood flow